Last reviewed · How we verify
Naftin® Gel 2%
At a glance
| Generic name | Naftin® Gel 2% |
|---|---|
| Also known as | Naftifine |
| Sponsor | Sun Pharmaceutical Industries, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis (PHASE1)
- Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |